BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
26.49
+0.28 (1.07%)
Dec 20, 2024, 4:00 PM EST - Market closed
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $5.01 billion as of December 20, 2024. Its market cap has decreased by -14.38% in one year.
Market Cap
5.01B
Enterprise Value
6.47B
1-Year Change
-14.38%
Ranking
Category
Stock Price
$26.49
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $5.01B, an increase of 50.80%. That is a compound annual growth rate of 7.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.01B | -28.72% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | 8.72B | 101.23% |
| Dec 31, 2019 | 4.33B | 30.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stevanato Group | 5.61B |
| Tempus AI | 5.60B |
| Corcept Therapeutics | 5.39B |
| RadNet | 5.38B |
| Telix Pharmaceuticals | 5.18B |
| Crinetics Pharmaceuticals | 4.97B |
| Alkermes | 4.81B |
| Krystal Biotech | 4.74B |